Genomic aberrations in non- small cell lung cancer and their impact on treatment outcome

Journal of Cancer Research and Therapeutics
Amrallah A MohammedArwa Al-Malki Atiah

Abstract

The therapeutic options of nonsmall cell lung cancer (NSCLC) therapy has been changed since the first discovery of activating epidermal growth factor receptor (EGFR) mutations and the development of specific EGFR tyrosine kinase inhibitors, which resulted in the evolution of "personalized medicine." There are a considerable number of genomic aberrations in NSCLC serving as potential predictive biomarkers and drug targets and still more. We summarized the molecular pathways, potential targets, and possible impact on disease outcome in NSCLC.

References

Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Dec 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ramaswamy Govindan
Jan 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shirin Khambata-FordMartin R Weber
Mar 25, 2011·Science Translational Medicine·Lecia V SequistJeffrey A Engelman
May 31, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sai-Hong Ignatius OuA John Iafrate
Aug 10, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio MarchettiFiamma Buttitta
Oct 5, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wolfram BruggerFederico Cappuzzo
Jan 5, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kristin BergethonA John Iafrate
Jan 25, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Filip JankuRazelle Kurzrock
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T
Feb 14, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·J De GrèveD Schallier
May 19, 2012·Pharmacogenomics·Clara MayoRafael Rosell
Aug 25, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kurtis D DaviesRobert C Doebele
Sep 15, 2012·Genome Research·Jeong-Sun SeoYoung Tae Kim
Dec 5, 2012·Chest·Jessica DoningtonUNKNOWN Thoracic Oncology Network of the American College of Chest Physicians and the Workforce on Evidence-Based Surgery of the Soc
Feb 13, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick J Roberts, Thomas E Stinchcombe
Mar 9, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Helena A YuGregory J Riely
Apr 9, 2013·Journal of Clinical Pathology·Keith M Kerr
Apr 24, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julien MazièresOliver Gautschi
Jun 4, 2013·The New England Journal of Medicine·Alice T ShawPasi A Jänne
Jun 22, 2013·Cancer Research·Rachel G LiaoPeter S Hammerman
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistMartin Schuler
Oct 29, 2013·Nature Medicine·Aria VaishnaviRobert C Doebele
Apr 11, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K M KerrUNKNOWN Panel Members
May 23, 2014·JAMA : the Journal of the American Medical Association·Mark G KrisPaul A Bunn
Jan 7, 2015·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 5, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Lynette M ShollUNKNOWN LCMC Investigators
Apr 30, 2015·The New England Journal of Medicine·Pasi A JänneMalcolm Ranson
Sep 16, 2015·Cancers·Vishal BoolellVinod Ganju

❮ Previous
Next ❯

Citations

Nov 28, 2017·Expert Review of Molecular Diagnostics·Clara Mayo-de-Las-CasasMiguel Angel Molina-Vila

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Lawrence H Einhorn
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición
Alma Delia Campos-ParraOscar Arrieta
© 2022 Meta ULC. All rights reserved